Search results
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
NBC New York· 4 days agoModerna and Merck said their experimental vaccine in combination with the therapy Keytruda improved survival and showed durable efficacy in a midstage study ...
Moderna Drug Candidate Tapped for FDA Rare-Disease Pilot Program
Morningstar· 1 day agoBy Colin Kellaher Moderna's mRNA-3705 drug candidate for a rare, genetic disorder of the liver has been chosen for a Food and Drug Administration pilot program aimed at addressing ...
COVID shots should target JN.1 variant in 2024-25 campaign, US FDA says
Reuters· 56 minutes agoThe U.S. Food and Drug Administration on Friday advised COVID-19vaccine manufacturers that new shots...
FDA Panel to Consider Which COVID Strain to Target in an Updated Vaccine
MedPage Today· 4 days agoIn the briefing document, the FDA staff gave a brief history of coronavirus vaccines, noting that...
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
Reuters via AOL· 4 days agoDetailed data on Monday from the 157-patient trial showed that after two and a half years, melanoma...
Adults 60+ Will Have 3 RSV Vaccines to Choose From This Year
Verywell Health via Yahoo News· 2 days agoThe Food and Drug Administration (FDA) has approved mRESVIA, a new vaccine made by Moderna, to help...
Moderna director Noubar Afeyan sells shares worth over $2.9 million By Investing.com
Investing.com· 7 days agoModerna , Inc. (NASDAQ:MRNA) director Noubar Afeyan has sold a total of $2,901,584 worth of company...
FDA approves Moderna’s mRNA RSV vaccine for older adults
KTBS Shreveport· 7 days agoThe shot, made by Moderna and sold under the name of mResvia, could be another tool in the country’s RSV arsenal in the fall. Moderna’s shot is the third ...
COVID Shots Should Target JN.1 Variant in 2024-25 Campaign, US FDA Says
US News & World Report· 1 hour agoThe advisers recommended the older strain as it is the only strain which Novavax - one of the vaccine makers - said it would be able to target with its shot. Separately, another ...
Moderna, Merck shares rise as combined melanoma therapy shows improved survival rate By...
Investing.com· 4 days agoThe vaccine, a critical component of Moderna’s pipeline, has bolstered investor confidence following...